Louis V. Gerstner Jr. Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Computational and Systems Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Mol Cell. 2020 Jul 2;79(1):167-179.e11. doi: 10.1016/j.molcel.2020.05.009. Epub 2020 Jun 3.
The identification of microRNA (miRNA) targets by Ago2 crosslinking-immunoprecipitation (CLIP) methods has provided major insights into the biology of this important class of non-coding RNAs. However, these methods are technically challenging and not easily applicable to an in vivo setting. To overcome these limitations and facilitate the investigation of miRNA functions in vivo, we have developed a method based on a genetically engineered mouse harboring a conditional Halo-Ago2 allele expressed from the endogenous Ago2 locus. By using a resin conjugated to the HaloTag ligand, Ago2-miRNA-mRNA complexes can be purified from cells and tissues expressing the endogenous Halo-Ago2 allele. We demonstrate the reproducibility and sensitivity of this method in mouse embryonic stem cells, developing embryos, adult tissues, and autochthonous mouse models of human brain and lung cancers. This method and the datasets we have generated will facilitate the characterization of miRNA-mRNA networks in vivo under physiological and pathological conditions.
通过 Ago2 交联免疫沉淀 (CLIP) 方法鉴定 microRNA (miRNA) 靶标,为这一重要的非编码 RNA 类的生物学提供了主要的见解。然而,这些方法在技术上具有挑战性,并且不容易适用于体内环境。为了克服这些限制并促进 miRNA 在体内功能的研究,我们开发了一种方法,该方法基于携带条件性 Halo-Ago2 等位基因的基因工程小鼠,该等位基因从内源性 Ago2 基因座表达。通过使用与 HaloTag 配体偶联的树脂,可以从表达内源性 Halo-Ago2 等位基因的细胞和组织中纯化 Ago2-miRNA-mRNA 复合物。我们在小鼠胚胎干细胞、发育中的胚胎、成年组织以及源自人类脑和肺癌的自发小鼠模型中证明了该方法的重现性和敏感性。该方法和我们生成的数据集将有助于在生理和病理条件下表征体内的 miRNA-mRNA 网络。